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Abstract
Background: During their blood meal, ticks secrete a wide variety of proteins that can interfere with their host’s defense
mechanisms. Among these proteins, lipocalins play a major role in the modulation of the inflammatory response.
Methodology/Principal Findings: We previously identified 14 new lipocalin genes in the tick Ixodes ricinus. One of them
codes for a protein that specifically binds leukotriene B4 with a very high affinity (Kd: 61 nM), similar to that of the
neutrophil transmembrane receptor BLT1. By in silico approaches, we modeled the 3D structure of the protein and the
binding of LTB4 into the ligand pocket. This protein, called Ir-LBP, inhibits neutrophil chemotaxis in vitro and delays LTB4-
induced apoptosis. Ir-LBP also inhibits the host inflammatory response in vivo by decreasing the number and activation of
neutrophils located at the tick bite site. Thus, Ir-LBP participates in the tick’s ability to interfere with proper neutrophil
function in inflammation.
Conclusions/Significance: These elements suggest that Ir-LBP is a ‘‘scavenger’’ of LTB4, which, in combination with other
factors, such as histamine-binding proteins or proteins inhibiting the classical or alternative complement pathways, permits
the tick to properly manage its blood meal. Moreover, with regard to its properties, Ir-LBP could possibly be used as a
therapeutic tool for illnesses associated with an increased LTB4 production.
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Introduction
Neutrophils are key players in the inflammatory response as
they constitute the first line of defense after infection or injury.
They are involved in phagocytosis and the degradation of micro-
organisms in the phagolysosome by the production of ROS
(Reactive Oxygen Species), antimicrobial peptides and proteases
such as elastase [1]. Neutrophils may also destroy pathogens
without phagocytosis by secreting antimicrobial factors into the
extracellular medium. Moreover, neutrophils play an essential role
in the control of the response to non-infectious inflammatory
stimuli. This control is carried out by serine proteases secreted at
the inflammation site, which are involved in the activation and
inactivation of chemokines and cytokines, activation of membrane
receptors and cleavage of adhesion proteins [2]. Furthermore,
neutrophils are recruited and activated at the inflammation site by
various factors including, in particular, leukotriene B4 (LTB4),
formyl methionyl leucyl phenylalanine (fMLP) [3], interleukin-8
(IL-8) [4,5], anaphylatoxin C5a [6,7] and Platelet Activating
Factor (PAF) [8,9]. During their blood meal, ticks can modulate
this pro-inflammatory neutrophil activation by means of factors
secreted by their salivary glands. For example, the saliva of the
hard tick Ixodes scapularis inhibits inflammatory neutrophil response
[10]. In addition, an anti-IL8 activity preventing the interaction of
IL-8 with its neutrophil receptors was described in the salivary
glands of several tick species (Dermacentor reticulatus, Amblyomma
variegatum, Rhipicephalus appendiculatus, Haemaphysalis inermis, Ixodes
ricinus) [11]. Similarly, a family of inhibitors of the alternative
complement pathway, specifically targeting properdin, a positive
regulator of C3 convertase, was identified and characterized in the
tick I. ricinus [12,13]. This activity prevents the production of C5a,
an important inflammatory mediator. Recently, Mans and Ribeiro
have demonstrated that some salivary proteins (moubatin, TSGP2,
TSGP3, TSGP4 and AM-33) from soft tick species (Ornithodoros
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moubata, Argas monolakensis) are able to scavenge arachidonic acid
derivatives such as thromboxane A2 (moubatin and TSGP3),
LTB4 (moubatin, TSGP2 and TSGP3) or leukotriene C4, D4 and
E4 (TSGP4 and AM-33) with high affinity [14,15].
Leukotriene B4 (LTB4) is a main actor in the recruitment and
activation of neutrophils [16]. It allows hyperadhesiveness of
neutrophils to endothelial cells [17,18], and induces degranulation
[19], superoxide anion secretion [20] and delayed apoptosis [21].
LTB4 is a small lipid molecule generated from arachidonic acid
via the 5-lipoxygenase pathway. Cell activation by LTB4 involves
2 protein G receptors called BLT1 and BLT2. Receptor BLT1 is
mainly expressed on the surface of leukocytes [22] whereas BLT2
expression is more ubiquitous, as it is observed on the surface of
several cell types [23]. These two receptors have different affinities
for LTB4. BLT1 has a dissociation constant (Kd) of about 1.0 nM
[24–26] whereas BLT2 has a Kd of about 23 nM [23]. Lastly,
LTB4 has many other functions in addition to its major role in
neutrophil activation. For instance, it is involved in the
recruitment and activation of eosinophils [27], T-lymphocytes
[28–30], monocytes [31], mastocytes [32] and dendritic cells [33],
thereby playing a central role during the development of the
inflammatory response.
In the previous study, we described the identification of 14
sequences (Lipocalin from Ixodes ricinus; LIR1 to LIR14) belonging
to the lipocalin superfamily in the tick I. ricinus. Convergent
experimental and in silico approaches allowed us to define one of
these proteins, LIR6, as an LTB4 binding protein. In accordance
with the nomenclature used for the three histamine-binding
proteins from the saliva of R. appendiculatus ticks (Ra-HBP), LIR6
was renamed Ir-LBP for ‘‘Ixodes ricinus leukotriene B4-binding
protein’’. We demonstrated that the protein Ir-LBP specifically
binds to LTB4 with a similar affinity to that of BLT1 and can
therefore act as an LTB4 scavenger. In silico analysis allowed to
model its structure supporting its specificity for LTB4. Moreover,
Ir-LBP interferes with neutrophil chemotaxis and apoptosis
induced by LTB4. Lastly, in vivo experiments established the
anti-inflammatory role of Ir-LBP through its action on neutrophils
located at the tick bite site.
Results
Biochemical characterization of Ir-LBP
We previously described the cloning and the expression of
recombinant Ir-LBP (previously named LIR6), a salivary tick
protein belonging to the lipocalin superfamily, which is able to
bind specifically leukotriene B4. We therefore undertook a refined
analysis of this binding. For this purpose, we produced a
recombinant form of Ir-LBP expressed in insect Sf9 cells, and
purified it by affinity chromatography on a Ni2+ chelate resin (see
Materials and Methods). The GenBank (http://www.ncbi.nlm.
nih.gov/Genbank) accession number for Ir-LBP protein is
AM055950. Highly purified recombinant Ir-LBP was first used
to determine the dissociation constant of Ir-LBP for LTB4 by
incubating it with increasing concentrations of 3H-LTB4. The
binding of LTB4 to Ir-LBP (three independent measurements) was
saturable with a Kd value of 0.59 nM60.57 (Figure 1A). This
value is close to that obtained for one of the 2 membrane receptors
specific to LTB4, namely BLT1, showing that Ir-LBP has a high
affinity for LTB4. Moreover, the linearity of Scatchard plot
analysis indicated the presence of a single high affinity LTB4
binding site on Ir-LBP.
The specificity of this binding was then evaluated by incubating
Ir-LBP with increasing concentrations of different eicosanoids
(LTB4, LTD4, LTC4, LTE4, 12(R)-hydroxyeicosatetraenoic acid
(HETE), 15(S)-hydroxyperoxyeicosatetraenoic acid (HpETE),
LTA4 methyl ester and 5 (S), 6 (R)-Lipoxin A4) in the presence
of a fixed concentration of 3H-LTB4 (Figure 1B). The results show
that only cold LTB4 is able to completely inhibit the binding of Ir-
LBP to 3H-LTB4 (IC50 = 5.7 nM). On the other hand, only at a
very high concentration of 10 mM were LTD4, LTE4 and 12(R)-
HETE able to decrease the binding of 1 nM of 3H-LTB4 to Ir-
LBP by approximately 30%. The other eicosanoids tested (LTA4
methyl ester, LTC4, 15(S)-HpETE and 5(S), 6(R)-Lipoxin A4)
were unable to compete at this concentration. These results show
that the scavenging of LTB4 by Ir-LBP is highly specific.
Furthermore, this interaction is reversible. The addition of an
excess of cold LTB4 (10 mM) for 2 h displaces the binding between
Ir-LBP and 1 nM of 3H-LTB4 (data not shown). Overall, these
results showed that Ir-LBP is a LTB4 scavenger protein binding to
it with a very high affinity (61 nM). This binding may only be
displaced by very high concentrations (10 mM versus nM) of
eicosanoid analogs.
In silico modeling of Ir-LBP
Construction of 3D models–Analysis of the models. In a
previous study, we modeled LIR2 based on the refined alignment
with Ra-HBP2 [34]. The same strategy was now used for Ir-LBP.
The alignment presented in Figure 2 was used as input for the
Modeler software. It should be noted that no gap was introduced
in regular secondary elements. Four models were built for Ir-LBP.
Their stereochemical validity was checked with Procheck [35]. No
residue was found in the disallowed phi/psi regions of the
Ramachandran plot (data not shown). In the models, the
secondary structure is similar to that of the template; variations
only occur in loops, as often for modeled structures. As for LIR2
[34], there is a potential disulfide bridge between Cys 187 and Cys
213, with no correspondence in Ra-HBP2.
As mentioned, the internal cluster of conserved residues is more
hydrophilic in Ir-LBP than the other LIRs or unrelated lipocalins
(see the accompanying paper): residues 91 (Thr), 93 (His), 115
(Thr), 158 (Thr) and 168 (Asn) are hydrophilic, like the two
conserved H1 residues (38 and 39). As shown in Figure 3B,
residues Asn 39, Tyr 48, Thr 91, His 93 and Thr 115 could
interact together and are thought to play a role in stabilizing the
fold, similar to the hydrophobic residues at the same positions in
other lipocalins.
It should be noted that Ir-LBP is significantly richer in positive
residues than the other LIRs. Notably, the Arg content of Ir-LBP
(10%) is largely superior to that of proteins in databanks (around
5%). For Ir-LBP, the corresponding V-loop, strand bC and the
surrounding loops, as well as loop bE-bF, are particularly rich in
charged residues. The mouth of the barrel contains more positive
than negative residues as shown in Figure S2, and may therefore
attract negatively charged ligands.
Analysis of the cavity. Globally, a segregation of residues
liable to interact with a ligand is observed in the cavity of all LIRs;
this is shown in Figure S1 for LIR2 and Ir-LBP. The top of the
cavity is enriched in hydrophilic residues and the bottom is more
hydrophobic. The profile of the cavity of LIRs suggests that they
may bind hydrophobic ligands such as fatty acids and hence
leukotrienes that are linear and have a hydrophobic tail. Three
major leukotrienes are involved in homeostasis and inflammation:
leukotrienes B4 (LTB4), C4 (LTC4) and D4 (LTD4). The latter
two have a peptidic moiety bonded near the carboxyl end and one
hydroxyl group on the aliphatic chain. For LTC4, the peptidic
moiety is composed of Glu-Cys-Gly and Cys-Gly for LTD4. LTB4
has two hydroxyl groups on the aliphatic chain and no peptidic
moiety. This could explain the specificity of Ir-LBP to LTB4.
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Molecular dynamics simulation of the interaction of Ir-
LBP with LTB4. To obtain some insight into the molecular
interactions between Ir-LBP and LTB4, molecular dynamics
simulations were carried out using Gromacs [36]. Before the
simulation, the LTB4-Ir-LBP complex was solvated and
minimized. The dynamic simulations lasted 3ns, including an
equilibration phase of about 1 ns. During simulations, the
hydroxyl groups and hydrophobic moiety potentially interact
with Ir-LBP cavity (figure 4A); all the Ir-LBP residues that are
suggested by the model to interact with LTB4 are represented in
Figure 3. On the other hand, the carboxyl group of LTB4 is
situated at the mouth of the barrel and is predicted to interact with
the solvent and the loops (figure 4B). Calculations suggest that one
hydroxyl group of LTB4 interacts with Arg 73 and Tyr 97 and the
second one interacts with Arg 53, Tyr 156 and Glu 188
(Figure 4B). The aliphatic tail is predicted to interact with
hydrophobic residues at the bottom of the barrel and two
histidines. As shown in Figure 4A, they are mainly aromatic and
might play an important role in stabilizing the hydrophobic
moiety.
The other LIRs do not bind LTB4 ‘‘in vitro’’, meaning that the
residues involved in LTB4 binding are not well conserved. Residue
73 is not conserved as positive; 97 is not conserved as hydrophilic,
except for LIR2 and LIR11; 53 is conserved as positive only for
LIR1, 7 and 11; the nature of residues 156 and 188 (hydrophilic
and negative, respectively) is conserved for all LIRs. The residues
suggested by the modeling to be involved in the stabilization of the
hydrophobic part of LTB4 are better conserved as they are
aromatic for all LIRs, except for residue 156. This conservation
analysis suggests that Arg 73 could play a role in LTB4 binding.
Together with the fact that Ir-LBP has a high net positive charge,
the presence of this residue may explain at least partially why Ir-
LBP is the only LIR to bind LTB4.
In summary, our ‘‘in silico’’ analysis casts light on properties fully
compatible with the experimental LTB4 binding: a barrel shaped
structure, the composition of the cavity and the adequate location
Figure 1. Binding of 3H-LTB4 to Ir-LBP. a) Saturation curve and scatchard analysis for LTB4 binding to Ir-LBP. b) Inhibition of 3H-LTB4 binding to
Ir-LBP by eicosanoı¨ds. The binding of 1 nM 3H-LTB4 was subjected to competition with the indicated concentrations of the indicated eicosanoı¨ds.
doi:10.1371/journal.pone.0003987.g001
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Figure 2. Alignment between Ir-LBP and Ra-HBP2 used as input for Modeler. * stands for an identical residue and N for similar residues.
Secondary structure elements (bA to bI in green and H1, H2 in red; V loop in blue) of Ra-HBP2 are indicated.
doi:10.1371/journal.pone.0003987.g002
Figure 3. Model of Ir-LBP with the residues corresponding to the conserved internal lipocalin cluster. A. The protein is viewed from the
top (right) and front (left). The protein is represented by a ribbon, colored by secondary structure succession. Positive residues are in blue,
hydrophobic residues in orange, hydrophilic residues in light blue, and Tyr in green. The corresponding V loop is not represented for the sake of
clarity. B. Details of the bottom of the cavity of Ir-LBP. The protein is represented by a ribbon. The strands are in yellow and H1 is in purple.
doi:10.1371/journal.pone.0003987.g003
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of critical amino-acid residues. It also suggests an explanation as to
why Ir-LBP is able to bind LTB4, as opposed to other LIRs.
Binding properties of selected mutants
In order to determine which amino acids of Ir-LBP are involved
in the binding to LTB4, we produced mutants designed on the
basis of the dynamic model established in silico. This model
suggests that the interaction with the hydroxyl group of LTB4
takes place on the one hand via Arg 73 and Tyr 97, and on the
other via Arg 53, Tyr 156 and Glu 188. Arg 73 was chosen to be
mutated rather than Tyr 97 because it is not conserved in the
other LIRs and should hence be specific for LTB4 binding. For the
interaction with the second hydroxyl group, the residue selected to
be mutated is Arg 73. The choice was made on this residue
because Glu 188 is conserved for all LIRs and should thus not be
as specific as Arg 73; furthermore, Arg 53 is bridged to Arg 73 by
an aspartic residue from the loop corresponding to the V loop in
Ra-HBP2. The two hydroxyl groups and the two Arg bridged by
Asp V could form an interacting network, further stabilizing the
binding with LTB4. Two single mutants were therefore produced
by replacing Arg 53 with threonine (R53T) and Arg 73 with
alanine (R73A). A double mutant (R53T/R73A) was also
produced by combining the 2 substitutions of the single mutants.
A null mutant was also constructed by replacing serine 124 with
threonine (S124T). Serine 124 is located close to the interaction
pocket but does not seem to be involved in binding with LTB4.
Therefore, the affinity of this mutant for LTB4 should not be
affected. These mutants and ‘‘wild type’’ Ir-LBP were expressed in
293T cells, and analyzed to determine their dissociation constant
for LTB4. As expected, the null mutant S124T had an affinity
(Kd = 0.45 nM60.01) for LTB4 similar to the ‘‘wild type’’ Ir-LBP
(Kd = 0.52 nM60.11). Mutant R53T showed no loss of affinity for
LTB4 (Kd = 0.43 nM60.07) whereas that of mutant R73A
increased approximately 1.7 times (Kd = 0.87 nM60.13). The
dissociation constant of the double mutant was increased by
approximately 10 times (Kd = 4.23 nM60.27). These results
suggest that Arg at position 73 is involved in LTB4 binding,
while the involvement of Arg at position 53 seems enhanced in the
frame of the double mutant configuration (R53T/R73A).
In vitro activity of Ir-LBP
Ir-LBP inhibits delayed neutrophil apoptosis induced by
LTB4. Neutrophils have a very short half-life (8–20 h) as they
undergo constitutive apoptosis, a process ensuring the elimination
of dead cells without the release of cytotoxic granules into the
surrounding tissues [37]. The inflammatory response is
accompanied by an expansion of the peripheral neutrophil pool
as a result of enhanced granulopoiesis and decreased neutrophil
apoptosis [38]. Among the different inflammatory mediators,
LTB4 is well known for its ability to delay neutrophil apoptosis
[21]. We therefore asked if Ir-LBP could counteract the anti-
apoptotic effects of LTB4. For that purpose, enriched neutrophil
populations were co-incubated in culture with LTB4 and Ir-LBP.
After 24 h of culture, apoptosis levels were significantly lower in
LTB4-treated neutrophils than untreated controls (Figure 5).
Addition of increasing concentrations of Ir-LBP to the culture
medium gradually inhibited LTB4-induced neutrophil survival
(Figure 5). The anti-apoptotic effects of LTB4 were completely
abolished when 1 and 2 mg/ml of Ir-LBP were used (Figure 5). Ir-
LBP alone, even at higher concentrations, had no measurable
effects on neutrophil apoptosis, even when higher Ir-LBP
concentrations were used (Figure 5). Taken together, these
results show that Ir-LBP is capable of inhibiting the anti-
apoptotic effects of LTB4.
Ir-LBP inhibits neutrophil transendothelial migration
induced by LTB4. One of the major actions of LTB4 is
chemotaxis of neutrophils to the inflammation site [16]. We
therefore sought to measure the effect of Ir-LBP on the diapedesis
aspect of this process by using a model of transendothelial
migration described in 1997 by Nohgawa and co-workers [39].
Figure 6 shows the results of two separate experiments. White
blood cells were obtained twice from a single volunteer at a 6 week
interval. Ir-LBP was indeed shown to have a dose-dependent effect
(starting at 0.5 mg/ml) on the transendothelial migration of
neutrophils. Neutrophil mortality determined by trypan blue
after 2 h of incubation was less than 5%, under each condition
(data not shown).
In vivo activity of Ir-LBP
In order to evaluate the in vivo role of Ir-LBP, we first assessed its
secretion by tick salivary glands. For that purpose, purified
recombinant Ir-LBP was analyzed using sera from rabbits
repeatedly infested by female I. ricinus ticks. Figure 7 shows that
recombinant Ir-LBP protein was effectively recognized by these
sera indirectly, showing that natural Ir-LBP protein is secreted in
the saliva during infestation. We then carried out RNA inhibition
experiments in vivo in the tick. Thus, we evaluated the effect of
siRNA injection in the tick, both on the capacity of salivary gland
Figure 4. Snapshots of the molecular dynamics simulation of Ir-
LBP interacting with LTB4. Ir-LBP is represented by a ribbon and
LTB4 in CPK. Tyr are green and positive, negative and hydrophobic
residues are blue, red and orange, respectively. A. Zoom on the carboxyl
group and the hydrophobic tail of LTB4. B. Zoom on two hydroxyl
groups of LTB4.
doi:10.1371/journal.pone.0003987.g004
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extracts to bind LTB4 and on the density, morphology and
survival of neutrophils at the bite site. First, siRNAs specifically
targeting Ir-LBP mRNA were synthesized and their effectiveness in
inhibiting the expression of recombinant protein Ir-LBP was
demonstrated in the 293T mammalian cell system by cotransfect-
ing siRNA and the plasmid Ir-LBP/pCDNA3.1/V5-His-TOPO
(data not shown). Then, salivary glands isolated from 5-day
engorged female ticks were incubated for 6 h with Ir-LBPsiRNA.
RT-PCR analysis of mRNA isolated from these salivary glands
showed a strong reduction in Ir-LBP mRNA level compared to the
Figure 5. Ir-LBP inhibits the anti-apoptotic effects of LTB4 in neutrophils. Human neutrophils were cultured for 24 h in the absence or
presence of LTB4 (10
27 M), graded concentrations of Ir-LBP (0.2, 0.5, 1 and 2 mg/ml), or both LTB4 (1027 M) and Ir-LBP (0.2 to 2 mg/ml). Apoptosis was
assessed by Annexin-V-FITC/PI staining and flow cytometry analyses. * Significantly different from the results obtained with untreated cells (p,0.05).
doi:10.1371/journal.pone.0003987.g005
Figure 6. Ir-LBP effect on transendothelial migration of freshly isolated neutrophils stimulated by LTB4. Results represent the number
of cells that cross the endothelial barrier after 2 h. Results were obtained from two independent experiments and are expressed as a fold increase
over control. One LTB4 concentration and four Ir-LBP concentrations, 10E27 M and a range from 0.2 mg/ml to 5 mg/ml respectively were used.
doi:10.1371/journal.pone.0003987.g006
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actin mRNA used as control (Figure 8B), confirming the results in
the endogenous system and demonstrating its specificity. Five mg of
protein extracts derived from these salivary glands were incubated
with 2 nM of 3H-LTB4. The results showed a reduction of
28.25% (SD = 2.01) in the binding capacity of the extract of Ir-
LBPsiRNA-treated glands compared to an extract from glands
treated with a non-relevant control siRNA (Figure 8A).
We also compared the density, morphology and survival of
neutrophils in the skin of tick-infested mice with or without
injecting silencing Ir-LBPsiRNA into the tick salivary gland. At the
tick bite site, the rostrum was deeply implanted, rupturing the
epidermis, dermis and hypodermis. Frequently, large accumula-
tions of inflammatory cells, mainly neutrophils, were detected in
the distended conjunctive tissue, especially around the blood
aspiration cavity. We observed a larger number of neutrophils in
the skin of mice infested with ticks treated by Ir-LBPsiRNA than in
mouse skin infested with either untreated ticks or ticks treated with
irrelevant siRNA or PBS. The neutrophil density, measured
morphometrically after immunolabeling neutrophils, was signifi-
cantly higher in skin infested with a tick treated with Ir-LBPsiRNA
(p,0.05) (Figure 9). Enlarged neutrophils with dilated nuclei were
found more often in the skin of mice infested with Ir-LBPsiRNA-
treated ticks than under the other conditions. These neutrophils
also appeared more intensely immunolabeled. This nuclear
morphology and the increase of staining are well documented as
being signs of cell activation (Figure 10). We did not observe any
difference in the quantity of apoptotic cells counted under the
different conditions. These apoptotic cells were mainly located in
the hypodermis at a distance from the blood aspiration cavity
(Figure 11).
Discussion
We previously described a family of sequences coding for
lipocalins in the salivary transcriptome of the hard tick I. ricinus.
These proteins were called LIR for ‘‘Lipocalin from I. ricinus’’ and
numbered from 1 to 14 (LIR1 to LIR14). Analysis of the
transcriptome of different tick species suggested that lipocalins
account for a large subgroup of the proteins expressed in the
salivary glands. Numerous lipocalins have also been identified in
both hard and soft ticks (R. appendiculatus, D. reticulatus, I. scapularis,
O. moubata, A. monolakensis). Some of these (Ra-HBP, SHBP, IS-14
and IS-15) bind either histamine (Ra-HBP), 5-hydroxytryptamine
(IS-14 and IS-15) or both histamine and 5-hydroxytryptamine
Figure 8. Ir-LBP knockdown in tick salivary glands. A) Eight pairs
of salivary glands were incubated for 6 h with control or Ir-LBP siRNA.
Five mg of salivary gland extracts were incubated with 2 nM of 3H-LTB4.
B) RT-PCR analysis of RNA from control and Ir-LBP siRNA-treated salivary
glands using Ir-LBP or actin gene-specific primers.
doi:10.1371/journal.pone.0003987.g008
Figure 9. Density measurement of labeled neutrophils in skin
of tick-infested mice. The light histogram represents the percentage
of neutrophils per zone in skin sections of mice infested with control
ticks (n = 55). The dark histogram represents the percentage of
neutrophils per zone in skin sections of mice infested with ticks treated
with Ir-LBP siRNA (n = 35, **: p,0.05).
doi:10.1371/journal.pone.0003987.g009
Figure 7. Western blot analysis of sera from repeatedly bitten
rabbits. Five hundred nanograms of recombinant Ir-LBP were
submitted to SDS-PAGE and analyzed by western blot using pooled
serum from two naı¨ve rabbits (lane 1) and rabbits infested three times
by I. ricinus female ticks (lane 2). *: unspecific band.
doi:10.1371/journal.pone.0003987.g007
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(SHBP) [40–42]. Others scavenge thromboxane A2 (moubatin and
TSGP3), LTB4 (moubatin, TSGP2 and TSGP3) or leukotriene
C4, D4 and E4 (TSGP4 and AM-33) with high affinity [14–15]. In
the accompanying paper, we attempted to determine the role of
LIRs by measuring the binding capacity of these proteins to
different ligands (histamine, 5-hydroxytryptamine, ADP norepi-
nephrine, PAF, prostaglandins D2 and E2, and LTB4 and LTC4),
known to act in the inflammatory response or, more generally, in
hemostasis. Only LIR6 could specifically bind one of them,
namely LTB4, and was therefore renamed Ir-LBP; the other LIRs
bind neither LTB4 nor the other ligands tested. On the basis of in
silico models constructed for the LIRs [34], we performed an in-
depth analysis which provided clues about the structure,
explaining the interaction between Ir-LBP and LTB4. Among
all LIRs, Ir-LBP is the richest in positive residues and should
therefore be more potent in attracting a negative ligand. By using
dynamic simulations, we suggest that the two hydroxyl residues of
LTB4 are interacting stably with 5 hydrophilic residues (2 Arg, 2
Tyr and 1 Glu), inside the barrel of Ir-LBP. Moreover, according
to this model, the aliphatic tail of LTB4 is stabilized by
hydrophobic interactions at the bottom of the barrel, and notably
4 aromatic residues (two Tyr, a His and a Trp). It should be noted
that Arg 73, which interacts with the first hydroxyl group, is not
conserved in any other LIR. Hence it is involved in the binding
specificity of Ir-LBP and plays a key role in ligand binding as
confirmed by mutational analysis (which also showed that it exerts
its role in cooperation with Arg 53).
Two membrane receptors for LTB4, BLT1 and BLT2, have
been identified so far. Their dissociation constant (Kd) values are
approximately 1 nM for BLT1 and 23 nM for BLT2. In the
present paper, we show that the binding of Ir-LBP to LTB4 is
highly specific, reversible and saturable, and also that the high
affinity (in the nM range) of Ir-LBP for LTB4 permits Ir-LBP to
compete with LTB4 membrane receptors, thus impeding the
transmission of the secondary messengers that are the initial steps
of the cellular response.
In the course of an inflammatory response, LTB4 is one of the
principal mediators involved in the recruitment and activation of
neutrophils. It is responsible for neutrophil chemotaxis, adhesion
to the blood vessel endothelium, transmigration, and degranula-
tion, and promotes a delay in apoptosis. In this study, we showed
that Ir-LBP influences endothelial transmigration of neutrophils,
and delays their entrance into apoptosis induced by LTB4. During
transmigration, LTB4 acts both on neutrophils, by inducing their
migration, and on endothelial cells, by permitting diapedesis.
LTB4 indeed induces the expression of CD54 protein (ICAM-1),
allowing neutrophils to adhere to endothelial cells [17]. By
sequestering LTB4, Ir-LBP prevents LTB4-dependent transmi-
gration of neutrophils, and probably prevents the concomitant
expression of proteins induced by LTB4, both in neutrophils and
Figure 10. Nuclear morphology of immunolabeled neutrophils in the skin, close to the aspiration cavity. Panel A shows the enlarged
nuclear morphology of neutrophils and intense immunolabeling using anti-mouse NIMP-R14 neutrophil antibody (in red) in a skin section of a mouse
infested with a Ir-LBP siRNA-treated tick. Panel B illustrates the nuclear morphology and labeling aspect of neutrophils (in red) in a skin section of a
mouse infested with a control tick (1006).
doi:10.1371/journal.pone.0003987.g010
Figure 11. Fluorescence Detection of apoptotic cells. Panel A shows apoptotic cells (stained in red with the ApopTag kit) in a skin section of a
mouse infested with a Ir-LBP siRNA-treated tick. Panel B shows apoptotic cells stained with the same technique in a skin section from a mouse
infested with a siControlRNA-treated tick.
doi:10.1371/journal.pone.0003987.g011
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endothelial cells. Moreover, neutrophils have a half-life of 8 to
20 h and then constitutively enter apoptosis. However, apoptosis
may be delayed by different mediators, such as LTB4. As
expected, Ir-LBP inhibits the delay of neutrophil apoptosis
induced by LTB4. Both Ir-LBP effects on transmigration and
apoptosis are dose-dependent. At higher concentrations of Ir-LBP,
the results are identical to those observed in the absence of LTB4,
suggesting that Ir-LBP had captured all the available active LTB4.
As a result, we infer that Ir-LBP, by binding LTB4, is a competitor
for the host BLT1 and BLT2 membrane receptors. Similar results
were observed with synthesized BLT1 and BLT2 antagonists. For
example, ONO-4057, a BLT1 and BLT2 antagonist, totally
inhibits endothelial transmigration of neutrophils [39]. Similarly,
CP-105696 and SB201146, both BLT1 antagonists, are capable of
inhibiting the apoptosis delay induced by LTB4 [43,44].
Finally, we have also evaluated the role of Ir-LBP in the
interaction of I. ricinus female ticks with their host. The recognition
of recombinant Ir-LBP by sera from repeatedly bitten animals
shows that their immune system has been in contact with the
natural protein. This suggests that the protein is injected in the
animal within the saliva. Moreover, we have also shown that I.
ricinus salivary gland extracts harbour binding activity to LTB4.
RNA interference experiments demonstrated the involvement of
Ir-LBP in this activity as tick salivary glands submitted to ex vivo Ir-
LBP siRNAs partially lose their ability to bind LTB4. Taken
together, these results show that Ir-LBP acts in vivo as a LTB4
‘‘scavenger’’. Nevertheless, although the expression of Ir-LBP is
inhibited, 70% of the LTB4-binding capacity remain. This
suggests that there are probably other LTB4-binding factors. As
mentioned in the accompanying paper, ticks express paralogue
families that can fulfill the same function. It is therefore likely that
there are other lipocalins (on top of non lipocalin proteins) able to
bind LTB4 in the tick salivary gland.
In vivo RNAi was also performed by injecting Ir-LBP siRNA or
irrelevant siRNA into ticks before putting them on mice. When
skin biopsies were analyzed on cryosections five days later, clear
differences were apparent between Ir-LBPsiRNA and control
samples. Bite sites of Ir-LBPsiRNA-treated ticks appeared larger
and more populated by neutrophils than those of control or
irrelevant siRNA-treated ticks. We propose that the saliva of Ir-
LBPsiRNA-treated ticks exerts a higher chemoattractant effect,
likely as a consequence of a lower LTB4 scavenging potential. The
neutrophils also appeared larger than those in control tick bite
sites; in particular, the morphology of the nuclei was changed,
appearing enlarged with less condensed chromatin. Here, too, it is
likely that Ir-LBPsiRNA treatment, and therefore lower levels of
Ir-LBP protein reduced the neutralization of LTB4, thus allowing
a higher degree of activation of neutrophils. Ir-LBPsiRNA
injection of the ticks also gave rise to more intense immunostaining
of neutrophils around the bite site; since the antibody target in this
assay is a membrane antigen, it is likely that yet another
consequence of Ir-LBPsiRNA–treatment of ticks is a more efficient
degranulation following activation of neutrophils. On the opposite,
we could not determine any difference in the apoptotic status of
neutrophils between control and Ir-LBPsiRNA conditions. This
suggests that Ir-LBP does not influence neutrophil apoptosis in vivo,
or alternatively that, in vivo, a reduction of apoptosis after Ir-
LBPsiRNA treatment is hard to quantify due to the very low basal
level of apoptotic neutrophils detected in normal situations. This
low level might itself result from a continuous aspiration of blood
and tissues removing living and dying cells. It has also been
reported that activated neutrophils undergo a peculiar cell death
process different from apoptosis [45] which could escape detection
by the kit used. Finally, other molecules (than LTB4) such as
TNFa or IL8 are released following tissue alteration by the tick
rostrum, which can also modulate neutrophil apoptosis. They
could on their own be sufficient, so that a change in LTB4
concentration would not influence neutrophil apoptosis.
According to our in vivo observations, tick saliva contains a factor
able to reduce neutrophil chemotaxis and activation, which matches
the in vitro ability of Ir-LBP to block LTB4. After Ir-LBP siRNA
injection, however, the engorgement of the ticks was not affected in
any means. Thus, in vivo, Ir-LBP delivered within the saliva could
repress neutrophil influx and activation at the tick bite site, but this
impairment appeared insufficient to alter the tick blood meal.
Concluding remarks
This study addressed the biochemical function and physiological
role in the tick blood meal of Ir-LBP. Ir-LBP has the capacity for
very high affinity binding of LTB4, one of the principal mediators
of the neutrophil-associated inflammatory response. In vitro, Ir-LBP
competes with the natural LTB4 receptors in order to inhibit the
transendothelial migration of neutrophils, as well as the apoptosis
delay naturally induced by LTB4. In vivo, Ir-LBP is partially
responsible for the LTB4 binding properties of tick salivary glands,
as well as the reduction of neutrophil activation at the bite site.
These elements show that Ir-LBP is a ‘‘scavenger’’ of LTB4,
which, in combination with other factors, such as ‘‘histamine-
binding protein’’ or proteins inhibiting the classical or alternative
complement pathway, permits the tick to properly manage its
blood meal. Moreover, with regard to its properties, Ir-LBP could
possibly be used as a therapeutic tool for illnesses associated with
an increase of the production of LTB4, such as Chronic
Obstructive Pulmonary Disease (COPD), rheumatoid arthritis,
psoriasis and inflammatory bowel disease, Crohn’s disease and
ulcerative colitis. Currently, BLT1 antagonists, such as LY29311,
are being developed, but they may generate invalidating side
effects due to their direct action on membrane receptors directly
connected with the cellular machinery. Another therapeutic
approach is to use LTB4 scavengers, like Ir-LBP. Later
experiments will seek to determine the potential of Ir-LBP to
become an effective therapeutic tool for any of these pathologies.
Materials and Methods
Ticks, salivary gland extracts and saliva
Ixodes ricinus ticks were bred and maintained at the University of
Neuchaˆtel Institute of Biology (Switzerland). Colony founders were
initially collected in the woodland near Neuchaˆtel and have been
maintained on rabbits or Swiss mice for over 20 years. For the
experiments described in this paper, pairs of adult (one female and
one male) ticks were allowed to anchor and feed on rabbits for the
indicated periods.
Animals
Animal care and experimental procedures were carried out in
accordance with the Helsinki Declaration (Publication 85-23,
revised 1985), local institutional guidelines (laboratory license nu
LA 1500474) and the Belgian law of August 14th, 1986 as well as the
royal decree of November 14th, 1993 on the protection of laboratory
animals. Studies were carried out using female New Zealand White
Rabbits weighing about 3 kg obtained from Harlan (The Nether-
lands) and 8 week-old NMRI female mice weighing 20 to 25 g,
obtained from Elevage Janvier (Le Genest-St-Isle, France).
In silico approaches
Modeling of the LIRs 3D structure. 3D models of LIRs
were built using the Modeler program [46]. This method uses
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sequence homology between the protein of interest and a protein
whose 3D structure is known to predict a three-dimensional
model. The protein we use as model is Ra-HBP2 (pdb code:
1QFT). The primary alignment was obtained using ClustalW [47]
and corrected by taking the conserved interactions of the lipocalin
family (as described in [34]) into account. The resulting alignment
is used as input for Modeler4.
The stereochemical quality of the 3D models is then checked
using Procheck [35]). It contains 95% of WY angle pairs in the
allowed regions of the Ramachandran plot, indicating a correct
stereochemistry. The PROF prediction of secondary structure was
obtained through the PredictProtein server (http://cubic.bioc.
columbia.edu/predictprotein/) [48].
Molecular dynamics simulations. The molecular
dynamics simulations were performed with the Gromacs 3.3
program [49,36] using the Gromos 96 forcefield (43a2; with
improved alkane dihedrals), for 3 ns at neutral pH. The LTB4
molecule was constructed in Hyperchem (release 7 for Windows-
Hypercube Inc.). The charge distribution was calculated using a
semi-empirical method. The structure was optimized with a
steepest descent completed by the Polak-Ribiere conjugated
gradient procedure. The LTB4 was then converted to the
Gromacs format using PRODRG server and manually
optimized to fit the forcefield [50].
The model was solvated in a cubic box (75/60/60 A˚) with 7915
simple point charge (SPC) water molecules and simulated using
periodic boundary conditions. Van der Waals interactions were
truncated at 12 A˚. The electrostatic interactions were treated
using the particle mesh Ewald (PME) algorithm with a 10-A˚
truncation. The model was minimized by 2000 steps of steepest
descent and 1000 steps of conjugate gradient and then equilibrated
at the desired temperature and pressure for 50 ps, with all atom
restraints except hydrogens, followed by 1 ns free of any atomic
restraints. The time step for dynamics was 2.0 fs. The LINCS
algorithm was used to satisfy bond constraints [51]. Temperature
was controlled using a weak coupling to a bath of constant T
(300K; coupling time of 0.1 ps) and pressure by a weak coupling to
a bath of constant P (1 atm, coupling time of 0.5 ps) with the
Berendsen method [36].
Site-directed mutagenesis of Ir-LBP in pCDNA3.1/V5-His-
TOPO
Mutants were produced by using the QuickChange PCR
mutagenesis kit (Stratagene). The following PCR primers were
used to generate R57T, R68A, S124T single mutants and the
R57T-R68A double mutant: 59-CAGAGTACGTACTGGCG-
TACACCACTTTTCAAGATATTGAAAG-39 (R57Tforward),
59-CTTTCAATATCTTGAAAAGTGGTGTACGCCAGTAC-
GTACTCTG-39 (R57Treverse), 59-GATATTGAAAGGA-
CACGTATTGCTAGATGCGTGAGTGCTAC-39 (R68Afor-
ward), 59-GTAGCACTCACGCATCTAGCAATACGTGTCC-
TTTCAATATC-39 (R68reverse), 59-TCCCAACCTAATGCTA-
ATGTCAACATATCACAACGAAAGTGATGA-39 (S124Tfor-
ward), 59-CTTCATCACTTTCGTTGTGATATGTTGACAT-
TAGCATTAGGTTGG-39 (S124Treverse); where the underlined
nucleotides generate the mutation. Supercompetent XL-1-Blue
cells were transformed according to the manufacturer’s instruc-
tions, and the plasmids were purified to confirm the sequence
modifications by sequencing.
Expression and purification of recombinant proteins
Subconfluent 293T cells in 35-mm diameter wells (Orange
Scientific) were transfected with 2 mg plasmid DNA and 6.0 ml
Fugene 6 (Roche Biochemicals) in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) without FCS. The medium was
harvested after 72 h. Pooled supernatants were cleared by
centrifugation, concentrated 10-fold by filtration on 10000
NMWL membranes (Millipore), ultracentrifuged at 140,000 g
before use, and finally stored at 280uC. Concentrated culture
supernatants were analyzed by western blotting on a Hybond ECL
membrane (GE healthcare) using an anti-V5 primary antibody
(Invitrogen), an IgHRP conjugate as secondary antibody and the
ECL detection reagent (GE healthcare) according to the
manufacturer’s instructions. The coding regions of Ir-LBP were
amplified by PCR (94uC for 30 s, 56uC for 30 s, 72uC for 1 min.;
30 cycles) using ExTaq DNA Polymerase (Taqara). The PCR
product was inserted into the pBlueBac4.5/V5-His Topo vector
(Invitrogen) in frame with the coding sequence of the V5 and His
epitopes at the C-terminus. Recombinant baculoviruses were
generated by recombination between pBlueBac/Ir-LBP and Bac-
N-Blue linear DNA virus (Invitrogen). Recombinant viruses were
selected and amplified according to the manufacturer’s instruc-
tions. Sf9 cells were infected with a high-titer stock of recombinant
baculovirus and were incubated for 72 h at 27uC in Sf900 II
serum-free medium (Invitrogen). Recombinant Ir-LBP proteins
were purified from the cell culture supernatant by affinity
chromatography on a His-Trap column (GE Healthcare). Proteins
were recovered in 50 mM NaH2PO4 buffer (pH 7.5) containing
300 mM NaCl and 250 mM of imidazole.
Binding assays
The dissociation constant was measured in PBS (pH 7.4) using
purified Ir-LBP and an increasing amount of 3H-LTB4. Non-
specific binding was determined by measuring bound radioactivity
in the absence of Ir-LBP. Protein precipitation with polyethylene
glycol 8000 was used to separate bound from free histamine [52].
Protein-bound radioactivity was determined with a Wallac 1409
scintillation counter. Saturation experiments were analyzed by
non-linear regression using the curve fitting program GraphPad
PrismH (GraphPad software, San Diego, CA, U.S.A.), B = (Bmax
[F])/KD+[F]), where B is the amount of bound ligand at
equilibrium, Bmax is the maximum number of binding sites, [F]
is the concentration of free ligand and KD is the ligand
dissociation constant. Competitive binding assays were performed
using purified Ir-LBP with 1 nM of 3H-LTB4 and an increasing
amount of unlabelled competitor for 2 h.
Cell sorting, culture, and treatment for apoptosis assays
Human blood neutrophils were obtained from buffy coats
(Transfusion Center, Liege, Belgium). Neutrophils were separated
from mononuclear cells by density centrifugation (Histopaque;
Sigma-Aldrich). Contaminating erythrocytes were removed from
the neutrophil fraction by hypotonic lysis. Neutrophil purity,
determined by counting cytospin preparations stained with Diff-
Quick (Dade Behring), was always .95%. Neutrophils were
cultured at a density of 26106 cells/ml in RPMI-1640
supplemented with 1% glutamine, 10% FCS, 50 mg/ml strepto-
mycin, and 50 IU/ml penicillin (all from Gibco BRL). Neutrophils
were cultured in the absence or presence of 1027 M LTB4 (Sigma-
Aldrich) and/or 0.2–2 mg/ml Ir-LBP.
Apoptosis assays
Apoptosis was assessed by staining with Annexin-V-FITC and
propidium iodide (PI) using the Annexin-V-FLUOS staining kit
(Roche), following the manufacturer’s recommendations. Flow
cytometry analyses were performed with a FACSAriaTM (BD
Biosciences).
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Cells and culture for transendothelial assay
Ea.hy926 cells, an endothelial cell line derived from the human
umbilical vein, were used. For the assay. These cells closely
resemble HUVEC and maintain several characteristics of
differentiated endothelium. The cells were allowed to reach
confluence in chambers containing Dubelcco’s Modified Eagle’s
Medium (DMEM) (Cambrex), supplemented with 10% Fetal Calf
Serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin and HAT (1000 mM hypoxanthine, 0.4 mM ami-
nopterin, 16 mM thymidine).
Leukocyte-enriched fractions. Cells were prepared from
peripheral blood from one healthy volunteer. Citrated blood was
mixed with an equal volume of 6% dextran/0.9% NaCl solution
and allowed to stand for 1 h at room temperature. Cell fractions
were then recovered and spun at 1150 rpm for 12 min at 4uC.
Pellets were re-suspended in ammonium chloride and, after 15 min,
spun at 1300 rpm for 6 min at 4uC. This step was repeated until no
red blood cells remained. Purity of preparations was .75%
neutrophils as judged by Cell-dyn 1600 (Abbott) and by
morphological examination with May-Gru¨nwald Giemsa staining.
Transendothelial assay
The protocol described by Nohgawa et al. was used for this test.
In brief, isolated cells were re-suspended at a minimum concentra-
tion of 56106 cells/ml in RPMI containing 10% FBS and added to
the upper chamber above the endothelial monolayer. We used the
same medium with or without LTB4 (10E-7 M) and/or Ir-LBP (0.2
to 5 mg/ml). After 2 h at 37uC, the upper chambers were removed
and cells in lower chambers were counted.
To be sure that the observed effect was really linked to
neutrophils, and not to other concurrent cell types, we evaluated
the cell type in the lower chamber by morphological examination
with May-Gru¨nwald Giemsa staining (data not shown). Each time,
there were more than 99% neutrophils.
siRNA silencing in 293T cells
Three siRNA (59-AGUGCUACAUUGCGAUACATT-39, 59-
AUGCUAAUGUCAUCAUAUCTT-39 and 59-GGUUAUAU-
UGGACCUUGUATT-39; Sigma, Belgium) were designed to target
specifically Ir-LBP mRNA. 293T cells were co-transfected with
500 ng of Ir-LBP/pCDNA3.1/V5-His-TOPO and 100 ng of each
of the siRNA using the X-tremeGENE siRNA transfection reagent
(Roche) according to the manufacturer’s recommendations. Seventy-
two h post transfection, culture supernatants were harvested, and the
protein expression was analyzed by Western blot.
Ex vivo SiRNA silencing in salivary gland extracts
The salivary glands from 10 partially (5-day) fed female ticks
were incubated for 6 h at 37uC in the presence of 5 mg of control
siRNA duplexes (Eurogentec) or a combination of the 3 Ir-LBP
siRNA or buffer alone in a total volume of 200 ml of incubation
buffer TC-199 (Sigma) containing 20 mM MOPS, pH 7.0.
RT-PCR analysis to confirm gene silencing
Messenger RNA from salivary gland extracts was isolated by
oligo-dT chromatography (MicroFastTrack 2.0 mRNA Isolation
Kit, Invitrogen). Reverse transcription was routinely performed in a
20 ml standard RT reaction mixture according to the manufactur-
er’s instructions (First-Strand cDNA Synthesis System, Invitrogen)
using the oligo dT primer. PCR was routinely performed in 50 ml of
standard Takara buffer containing 2.5 U of Taq polymerase
(Takara Ex Taq, Takara, Japan), 10 pmoles of each primer, and
2.5 nmoles of each dNTP (Takara). PCR cycling conditions were as
follows: 30 cycles of 95uC 30 s/58uC 30 s/72uC 1 min 30 s
preceded by an initial 4 min denaturation step at 95uC and followed
by a final 10 min extension at 72uC. Primers (sense-primer: 59-
GCCACCATGCTTAGAATAGCGGTGGTTGC-39 and anti-
sense primer: 5- CTCGGGTCCCTTGCGTTTGCA-39) designed
to amplify the Ir-LBP open reading frame were used to perform
RT-PCR analysis of the transcripts. A pair of primers designed to
amplify a 1,131 bp fragment from the actin open reading frame
(sense-primer; 59-ATGTGTGACGACGAGGTTGCC-39 and an-
ti-sense primer; 59-TTAGAAGCACTTGCGGTGGATG-39) were
used as controls. 10 ml of the PCR reactions were analyzed on a 2%
agarose gel.
Tissue preparation, immunohistochemistry and
morphometry
Mouse skin fragments with 5-day engorged ticks were
embedded in TissueTek (Sakura) and stored at 220uC. Cryosec-
tions (10 mm-thick) were placed on poly-L-lysine coated slides and
air-dried. Sections were then fixed in PBS containing 1%
paraformaldehyde (PFA) for 10 min at room temperature and
stored at 220uC.
Neutrophils were detected using the indirect biotin-streptavidin
immunoperoxidase technique on skin sections containing tick
rostra. Briefly, slides were rehydrated, washed 2 times for 2 min
with H2O2 and incubated with a 1/100 dilution of anti-mouse
neutrophil antibody (NIMP-R14; Abcam) for 1 h at room
temperature. They were rinsed 3 times with PBS and incubated
with biotin-conjugated anti-rat IgG for 1 h at room temperature.
After 3 washes, they were incubated with streptavidin HRP-
conjugate (Dako Cytomation) for 30 min at room temperature.
HRP was revealed with AEC (Zymed). The sections were then
counterstained with Carrazi haematoxylin and mounted in
glycergel (Dako Cytomation).
Apoptotic cells were detected using ApopTag kit (Chemicon)
according to the manufacturer’s instructions.
We used a morphometrical technique to quantify labeled
surfaces. Entire skin sections were digitalized. Labeled surfaces
were measured using ImageJ software (National Institutes of
Health), in 5 different zones per skin section. The ratios between
the labeled surface and the total zone surface were calculated and
the means of these ratios were compared between mouse skins
infested with a tick treated with siIr-LBPRNA and mouse skins
infested with control uninjected ticks or injected with PBS or
siControlRNA. The values were compared by nonparametrical
statistical analysis (Mann-Whitney test).
Statistical analysis
Data are presented as means6standard deviation (SD). The
differences between mean values were estimated using an
ANOVA with subsequent Fisher’s protected least significant
difference tests. A value of p ,0.05 was considered significant.
The results presented are representative of three similar experi-
ments.
Supporting Information
Figure S1 Top view of Ir-LBP (center), LIR2 (right) and Ra-
HBP2 (1QFT) (left). Negative and positive residues are in red and
blue, respectively. The proteins are positioned as indicated by the
ribbon representation of Ir-LBP.
Found at: doi:10.1371/journal.pone.0003987.s001 (9.45 MB TIF)
Figure S2 Residues (represented as sticks and balls) of the cavity
of LIR2 (left) and Ir-LBP (right) capable of interacting with a
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ligand. Proteins are represented by a ribbon, colored by secondary
structure succession. Positive and negative residues are in dark
blue and red, respectively, hydrophilic and hydrophobic residues
are light blue and orange respectively, and Tyr is green.
Found at: doi:10.1371/journal.pone.0003987.s002 (8.22 MB TIF)
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